Ocular Therapeutix (OCUL) Inventory Average (2014 - 2026)

Ocular Therapeutix has reported Inventory Average for 13 years, with the latest figure at $3.8 million in Q2 2026.

• Inventory Average for Q2 2026 came in at $3.8 million, up 19.9% year-over-year; the trailing twelve-month figure through Jun 2026 was $3.8 million (up 19.9% YoY), and the FY2025 annual result was $3.3 million, up 23.55% from the prior year.
• Inventory Average climbed to $3.8 million in Q2 2026, from $3.7 million in the prior quarter.
• Over five years, Inventory Average peaked at $3.8 million in Q2 2026 and troughed at $1.3 million in Q1 2022.
• A 5-year average of $2.5 million and a median of $2.5 million in 2024 frame the typical range for Inventory Average.
• The widest annual swing landed in 2023, when Inventory Average surged 62.58%; it then gained 11.01% in 2024.
• A 5-year view of Inventory Average shows it stood at $1.8 million in 2022, then advanced by 29.64% to $2.3 million in 2023, then climbed by 19.36% to $2.7 million in 2024, then gained by 29.51% to $3.5 million in 2025, then increased by 7.25% to $3.8 million in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $3.8 million in Q2 2026, $3.7 million in Q1 2026, and $3.5 million in Q4 2025.